These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 14737103)

  • 1. p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis.
    Gao J; Huang HY; Pak J; Cheng J; Zhang ZT; Shapiro E; Pellicer A; Sun TT; Wu XR
    Oncogene; 2004 Jan; 23(3):687-96. PubMed ID: 14737103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation.
    Zhang ZT; Pak J; Huang HY; Shapiro E; Sun TT; Pellicer A; Wu XR
    Oncogene; 2001 Apr; 20(16):1973-80. PubMed ID: 11360181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth.
    Cheng J; Huang H; Zhang ZT; Shapiro E; Pellicer A; Sun TT; Wu XR
    Cancer Res; 2002 Jul; 62(14):4157-63. PubMed ID: 12124355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.
    Garcia-España A; Salazar E; Sun TT; Wu XR; Pellicer A
    Cancer Res; 2005 Feb; 65(4):1150-7. PubMed ID: 15734997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation.
    Wang XJ; Greenhalgh DA; Roop DR
    Mol Carcinog; 2000 Mar; 27(3):200-9. PubMed ID: 10708482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic loss of p53 gene is associated with genesis and maintenance, but not invasion, of mouse carcinoma in situ of the bladder.
    Cheng J; Huang H; Pak J; Shapiro E; Sun TT; Cordon-Cardo C; Waldman FM; Wu XR
    Cancer Res; 2003 Jan; 63(1):179-85. PubMed ID: 12517796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis.
    Mo L; Zheng X; Huang HY; Shapiro E; Lepor H; Cordon-Cardo C; Sun TT; Wu XR
    J Clin Invest; 2007 Feb; 117(2):314-25. PubMed ID: 17256055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of invasive mouse skin carcinomas in transgenic mice with mutations in both H-ras and p53.
    Zhang Z; Yao R; Li J; Wang Y; Boone CW; Lubet RA; You M
    Mol Cancer Res; 2005 Oct; 3(10):563-74. PubMed ID: 16254190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.
    Zhang ZT; Pak J; Shapiro E; Sun TT; Wu XR
    Cancer Res; 1999 Jul; 59(14):3512-7. PubMed ID: 10416618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathways of urothelial development and bladder tumorigenesis.
    Castillo-Martin M; Domingo-Domenech J; Karni-Schmidt O; Matos T; Cordon-Cardo C
    Urol Oncol; 2010; 28(4):401-8. PubMed ID: 20610278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.
    Wang Y; Zhang Z; Lubet RA; You M
    Oncogene; 2006 Feb; 25(8):1277-80. PubMed ID: 16247444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urothelial tumorigenesis: a tale of divergent pathways.
    Wu XR
    Nat Rev Cancer; 2005 Sep; 5(9):713-25. PubMed ID: 16110317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
    Karam JA; Shariat SF; Huang HY; Pong RC; Ashfaq R; Shapiro E; Lotan Y; Sagalowsky AI; Wu XR; Hsieh JT
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4400-6. PubMed ID: 17671122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency.
    Leder A; McMenamin J; Zhou F; Moran JL; Beier DR; Leder P
    Oncogene; 2008 Apr; 27(17):2456-65. PubMed ID: 17952114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke.
    Yao R; Wang Y; D'Agostini F; Izzotti A; Lubet RA; You M; De Flora S
    Exp Lung Res; 2005 Mar; 31(2):271-81. PubMed ID: 15824025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
    Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
    Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
    Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
    Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice.
    Dunn SE; Kari FW; French J; Leininger JR; Travlos G; Wilson R; Barrett JC
    Cancer Res; 1997 Nov; 57(21):4667-72. PubMed ID: 9354418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [p53 and prognosis of urothelial bladder tumors].
    Chopin D
    Pathol Biol (Paris); 1997 Dec; 45(10):893-7. PubMed ID: 9769954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.